Search

everythinglearnresearchcommunity

for

Search:↓

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Women know more about androgenetic alopecia than men.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

PRP injections can increase hair density in people with androgenic alopecia.

Higher substance P levels may cause discomfort in hair loss patients.

Light-based therapies show promise as safe treatments for hair loss.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Targeting IL-17 could help treat pattern hair loss.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Hair loss in men might be linked to programmed cell death.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.

Red and infrared light therapy improves hair growth in balding patients.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Botulinum toxin injections improved hair thinning in a woman with hair loss.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Herbal extract spray improved hair growth in a man with hair loss.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.